Real-World Treatment Patterns and Characteristics Among Patients with Agitation and Dementia in the United States: Findings from a Large, Observational, Retrospective Chart Review
Open Access
- 18 August 2020
- journal article
- review article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 77 (3) , 1181-1194
Abstract
Background: Few studies have examined patient characteristics and treatment patterns among patients with dementia and agitation in the United States (US). Objective: To examine real-world treatment patterns and characteristics of patients with agitation related to dementia who were treated with antipsychotics in US residential care and community-based settings. Methods: This retrospective chart review collected US physician-level data from patients 55 to 90 years old initiated on an antipsychotic medication for the treatment of agitation related to dementia from January 2018 to May 2018. Clinical characteristics and treatment patterns were assessed overall and stratified by residential care and community-based settings. Results: A total of 313 participating physicians, 59.5% of whom were primary care physicians, abstracted 801 patient charts (residential care: n = 312; community-based: n = 489). Of patients with agitation who were initiated on an antipsychotic, most patients (74.5%) were initiated within 3 months of the onset of their studied agitation episode, and 62.8% experienced multiple agitation episodes before initiation. While non-pharmacological therapies are recommended first-line approach for agitation in dementia, use of non-pharmacological therapy before initiation of antipsychotics was reported for only 37.8% of patients in residential care and 21.3% in community-based settings. Conclusion: Most patients were initiated on an antipsychotic treatment after multiple episodes of agitation and largely without initial non-pharmacological therapy, suggesting that current treatment guideline recommendations for first-line non-pharmacological intervention may not be adequately followed in clinical practice. Understanding the clinical burden and treatment patterns among dementia patients with agitation is imperative for effective disease management.Keywords
This publication has 35 references indexed in Scilit:
- Antipsychotics, Other Psychotropics, and the Risk of Death in Patients With DementiaJAMA Psychiatry, 2015
- Neuropsychiatric Symptoms as Predictors of Progression to Severe Alzheimer’s Dementia and Death: The Cache County Dementia Progression StudyAmerican Journal of Psychiatry, 2015
- Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definitionInternational Psychogeriatrics, 2015
- The course of neuropsychiatric symptoms in community-dwelling patients with dementia: a systematic reviewInternational Psychogeriatrics, 2014
- The Prevalence and Course of Neuropsychiatric Symptoms in Nursing Home Patients With Dementia: A Systematic ReviewJournal of the American Medical Directors Association, 2013
- Aripiprazole in the treatment of Alzheimer's diseaseExpert Opinion on Pharmacotherapy, 2013
- Atypical Antipsychotic Use in Patients With Dementia: Managing Safety ConcernsAmerican Journal of Psychiatry, 2012
- Predictors of Nursing Home Admission for Persons with DementiaMedical Care, 2009
- Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysisInternational Journal of Geriatric Psychiatry, 2008
- Treatment of Dementia in Community‐Dwelling and Institutionalized Medicare BeneficiariesJournal of the American Geriatrics Society, 2007